These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 13785770)

  • 1. Edathamil in the treatment of scleroderma and calcinosis cutis.
    WINDER PR; CURTIS AC
    Arch Dermatol; 1960 Nov; 82():732-6. PubMed ID: 13785770
    [No Abstract]   [Full Text] [Related]  

  • 2. Scleroderma. An evaluation of treatment with disodium edetate.
    NELDNER KH; WINKELMANN RK; PERRY HO
    Arch Dermatol; 1962 Sep; 86():305-9. PubMed ID: 14478876
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapy of systematized scleropathy (progressive scleroderma) and systematized sarcoidosis with the chelating agent Na2EDTA].
    LANGHOF H; ZABEL H
    Dtsch Gesundheitsw; 1962 Feb; 17():188-97. PubMed ID: 14462154
    [No Abstract]   [Full Text] [Related]  

  • 4. [Progressive scleroderma with considerable electromyographical changes treated with chelating agents (E.D.T.A.)].
    da FONSECA
    J Med (Oporto); 1960 Feb; 41():469-76. PubMed ID: 13823810
    [No Abstract]   [Full Text] [Related]  

  • 5. [1st therapeutic trials of "chelating agents" (EDTA) in cases of scleroderma and of other fibrosclerotic processes of the dermal connective tissues].
    AGOSTINI A; ZANCA A
    G Ital Dermatol; 1961; 102():85-106. PubMed ID: 13859615
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of scleroderma with the new chelating agent, edathamil.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Aug; 80(2):187-94. PubMed ID: 13669744
    [No Abstract]   [Full Text] [Related]  

  • 7. Localized scleroderma and calcinosis cutis.
    WISE F
    Arch Derm Syphilol; 1946 Jul; 54():109. PubMed ID: 20992540
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of scleroderma with the disodium salt of ethylenediaminetetraacetic acid: a contribution to the toxicology of versenate. Part 1].
    HOESLI P
    Arzneimittelforschung; 1960 Feb; 10():65-74. PubMed ID: 14402320
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapy of scleroderma with the disodium salt of ethylenediamine-tetraacetic acid: a contribution to the toxicology of versenate. Part 2].
    HOESLI P
    Arzneimittelforschung; 1960 Mar; 10():177-81. PubMed ID: 14402321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sclerodactyly with digital and pre-rotular calcinosis (Thibierge-Weissenbach syndrome) preceded by Renaud's syndrome; results of treatment with a chelating agent (sodium salt of edathamil)].
    NICK J; CONTAMIN F; HARL JM; MORIN P
    Bull Mem Soc Med Hop Paris; 1957 Feb 1-15; 73(4-6):169-74. PubMed ID: 13413679
    [No Abstract]   [Full Text] [Related]  

  • 11. A technique for intravenous therapy in patients with scleroderma and in apprehensive children.
    LUNDY JS
    AMA Arch Derm; 1959 Aug; 80(2):226-7. PubMed ID: 13669755
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of the chelating agent edathamil disodium in acrosclerosis, sarcoidosis and other skin conditions with comments on tryptophan metabolism in sarcoidosis.
    JOHNSON SA
    Wis Med J; 1960 Oct; 59():651-5. PubMed ID: 13790343
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcinosis cutis: its relationship to scleroderma.
    MULLER SA; BRUNSTING LA; WINKELMANN RK
    AMA Arch Derm; 1959 Jul; 80(1):15-21. PubMed ID: 13660494
    [No Abstract]   [Full Text] [Related]  

  • 14. SYSTEMIC SCLERODERMA, CALCINOSIS CUTIS AND PARATHYROID HYPERPLASIA.
    SAMUELSSON SM; WERNER I
    Acta Med Scand; 1965 Jun; 177():673-84. PubMed ID: 14334660
    [No Abstract]   [Full Text] [Related]  

  • 15. Favorable response of calcinosis universalis to edathamil disodium.
    DAVIS H; MOE PJ
    Pediatrics; 1959 Nov; 24():780-5. PubMed ID: 13814456
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of experimental calcinosis cutis by aminoacetonitrile (AAN)].
    SELYE H; CANTIN M; JEAN P
    Arch Klin Exp Dermatol; 1960; 212():1-7. PubMed ID: 13749958
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of scleroderma and calcinosis circumscripta.
    DOUGLAS AH; RANDEL WH
    N Y State J Med; 1953 Jan; 53(1):87-9. PubMed ID: 13025727
    [No Abstract]   [Full Text] [Related]  

  • 18. [The therapy of scleroderma with chelating agents].
    NEJEDLY O; PIPER HG
    Hautarzt; 1960 Aug; 11():378-9. PubMed ID: 13728235
    [No Abstract]   [Full Text] [Related]  

  • 19. Para-aminobenzoic acid therapy in scleroderma and lymphoblastoma cutis.
    ZARAFONETIS CJ
    J Lab Clin Med; 1948 Nov; 33(11):1462. PubMed ID: 18933516
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of scleroderma by chelation].
    CORRALES H
    Rev Med Hondur; 1960; 28():84-7. PubMed ID: 13695652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.